21148 ⎘
Medicinal preparations containing antigens or antibodies; Antibodies ; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH AN ANTI-BCL-2 ACTIVE AGENT
#602Methods of diagnosing and treating fibrosis
#603NON-PEGYLATED LIPOSOMAL DOXORUBICIN TRIPLE COMBINATION THERAPY
#604METHODS OF INHIBITING TUMOR GROWTH USING BETA 5 INTEGRIN ANTAGONISTS
#605Human GM-CSF antigen binding proteins
#606Methods and apparatuses for endian conversion
#607TREATING CANCER
#608Antagonists of IL-6
#609Soluble tumor necrosis factor receptor treatment of medical disorders
#610Sequential Administration of Chemotherapeutic Agents for Treatment of Cancer
#611PCSK9 inhibitors and methods of use thereof
#612Combination Therapy of a Type II Anti-CD20 Antibody with an Anti-BCL-2 Active Agent
#613Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
#614Methods For Treating Diseases Using Antibodies to Aminophospolipids
#615Toll-like receptor 3 antagonists
#616Non-pegylated liposomal doxorubicin triple combination therapy
#617THERAPEUTIC AND PROPHYLACTIC METHODS FOR NEUROMUSCULAR DISORDERS
#618Pharmaceutical formulations
#619Rage fusion proteins
#620MULTICOMPONENT VACCINE
#621Antibodies which bind factor VIII
#622NON-PEGYLATED LIPOSOMAL DOXORUBICIN TRIPLE COMBINATION THERAPY
#623Anti-FcRH5 antibodies and immunoconjugates and methods of use
#624METHOD FOR TREATING MULTIPLE SCLEROSIS
#625Combination therapy with antibody-drug conjugates
#626Anti-system ASC amino acid transporter 2 (ASCT2) antibody
#627Targeted antibodies directed to DLL4
#628HMG1 antibody for treating inflammatory conditions
#629Human CGRP receptor binding proteins
#630Toll-like receptor 3 antagonists
#631Transferrin receptor antibodies
#632KIM-1 antibodies for treatment of TH2-mediated conditions
#633LINGO binding molecules and pharmaceutical use thereof
#634Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies
#635Method of inhibiting regulatory T-cell activity by administering an antibody that inhibits interleukin 35
#636COMBINATION THERAPY
#637Antibodies to IL-6 and use thereof
#638BSL2v1c2 polypeptides
#639Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
#640Genetically modified human natural killer cell lines
#641Genetically modified human natural killer cell lines
#642Dual variable domain immunoglobulins and uses thereof
#643Prostaglandin E2 binding proteins and uses thereof
#644COMPOSITIONS INCLUDING TRICIRIBINE AND TRASTUZUMAB AND METHODS OF USE THEREOF
#645SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONISTS IN THE TREATMENT OF DEMYELINATING DISORDERS
#646METHODS OF USING CD40 BINDING AGENTS
#647Polynucleotides and polypeptide sequences involved in the process of bone remodeling
#648Antagonists of HMG1 for treating inflammatory conditions
#649Methods and compositions for treating inflammatory conditions
#650Compositions, kits, and methods for the modulation of immune responses using galectin-1
#651NOTCH inhibition in the treatment of atherosclerosis
#652Soluble tumor necrosis factor receptor treatment of medical disorders
#653Compositions and methods for treatment of diabetic retinopathy
#654Pharmaceutical Composition for The Treatment or Prevention of Allergic Diseases, Use Thereof, and A Method for The Treatment or Prevention of Allergic Diseases
#655Methods and compositions for pulmonary administration of a TNFa inhibitor
#656COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH AN ANTI-BCL-2 ACTIVE AGENT
#657Antitumor Combination Comprising Substituted Acryloyl Distamycin Derivatives and Antibodies Inhibiting Growth Factors or Their Receptors
#658Antibodies that bind the glutamate ligand binding region of Notch1
#659Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#660Biomarkers For Anti-Nogo-A Antibody Treatment in Spinal Cord Injury
#661Vascular endothelial cell growth factor antagonists and uses thereof
#662Synergistic compositions for treating HIV-1
#663Vascular endothelial cell growth factor antagonists and uses thereof
#664GENETICALLY MODIFIED HUMAN NATURAL KILLER CELL LINES
#665Combination Therapy
#666Reagents and treatment methods for autoimmune diseases
#667Method of Using IL6 Antagonists with Mitoxantrone for Prostate Cancer
#668IMPROVING TREATMENTS
#669Methods and compositions for modulation of blood-neural barrier
#670Treatment methods using anti-CD22 antibodies
#671Vascular endothelial cell growth factor antagonists and uses thereof
#672Pharmaceutical Composition Of (+)-Erythro-Mefloquine And Its Use
#673Surface marker-directed cancer therapeutics
#674Compositions and methods including a recombinant human MAB that promotes CNS remyelination
#675Pharmaceutical formulations
#676Combination therapy
#677Genetically modified human natural killer cell lines
#678Antagonists of HMG1 for treating inflammatory conditions
#679Methods of diagnosing sepsis by measuring HMG1
#680Pharmaceutical preparation containing palladium complex compounds and the uses thereof for treating cancer and autoimmune disease
#681Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
#682Polynucleotides encoding BSL2v1c2-Ig
#683Use of antibodies against tumor-associated antigen
#684Methods of treating hemostasis disorders using antibodies binding the C1 domain of factor VIII
#685Method for treating multiple sclerosis
#686Organic compounds
#687Transferrin receptor antibodies
#688Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases
#689Combination therapies utilizing benzamide inhibitors of the P2X7 receptor
#690Compositions and methods for preventing erythropoietin-associated hypertension
#691Coadministration of transport protein with conjugated cobalamin to deliver agents
#692Vascular endothelial cell growth factor antagonists and uses thereof
#693Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications
#694Pharmaceutical kit comprising anti-human seminal plasma protein single chain antibody/human carboxypeptidase fusion protein and prodrug
#695Vascular endothelial cell growth factor antagonists and uses thereof
#696Therapeutic methods for muscular or neuromuscular disorders
#697Autoinjector comprising high concentration formulation of vedolizumab